Common drugs of abuse chart shows how they are abused and their street names. Useful for parents and employers.
The chart was designed to help understand the effects of drugs, ways used, street names and the average detection time,
| Drug class & drug analytes | Common drug names | Street names | Schedule | Ways used | Addiction | Drug metabolite | Detection time: urine | Detection time: oral fluid |
Common drugs of abuse: Opiates | ||||||||
|---|---|---|---|---|---|---|---|---|
| Codeine | Tylenol® #3 | Schoolboy | Schedule II by itself. Schedule III in combination. | Oral; intrarectal; intramuscular; subcutaneous | Moderate-to-low risk of physical or psychological dependence. Withdrawal symptoms may include drug craving, runny nose, yawning, sweating, insomnia, weakness, stomach cramps, etc. | Codeine, Morphine | 1-3 days | 1-2 days |
| Hydrocodone | Lorcet®, Lortab®, Hycodan®, Norco®, Vicodin®, Vicoprofen® | Hydros, Dones, Vics, Itchies | Schedule II by itself. Schedule III in combination. | Oral | Moderate potential of physical or psychological dependence. Withdrawal symptoms may include severe pain, pins and needles, sweating, extreme anxiety, restlessness, sneezing, etc. | Hydrocodone, Hydromorphone, Norhydrocodone | 1-3 days | 1-2 days |
| Hydromorphone | Dilaudid®, Hymorphan® | Juice, Dillies, M2s, Hospital heroin | Schedule II | Oral; intramuscular; intravenous; subcutaneous; intranasal; rectal; sublin-gual; transmucosal; buccal; transdermal | Moderate-to-high risk of physical or psychological dependence. Withdrawal symptoms may include shaking, cold sweats, diarrhea, vomiting, self-doubt, emptiness, etc. | Hydromorphone | 1-3 days | 1-2 days |
| Morphine | Avinza®, Kadian®, MS Contin®, MSIR®, Roxanol®, Embeda® | M, Morph | Schedule II | Smoking; snorting; oral; rectal; subcutaneous; intramuscular; intravenous; intrathecal | High potential for physical or psychological dependence. Withdrawal symptoms may include several stages ranging from drug craving and anxiety to vomiting or loss of appetite. | Morphine | 1-3 days | 1-2 days |
| Oxycodone | Tylox®, Percocet®, Percodan®, OxyContin®, OxyIR®, Roxicodone® | Oxy-coffins, Killers, Percs | Schedule II | Oral; intramuscular; intravenous; in-tranasal; subcutaneous; transdermal; rectal; epidural | Moderate-to-high risk of physical or psychological dependence. Withdrawal symptoms may include anxiety, panic attacks, nausea, muscle pain, fevers, etc. | Oxycodone, Oxymorphone, Roxycodone | 1-3 days | 1-2 days |
| Oxymorphone | Opana ER®, Opana IR®, Numorphan® | Blues, Nu-blues, Biscuits, Blue heaven | Schedule II | Intravenous; intramuscular; subcutaneous; oral; rectal; intranasal | High risk of physical or psychological dependence. Withdrawal symptoms may include anxiety, panic attacks, nausea, muscle pain, fevers, etc. | Oxymorphone | 1-3 days | 1-2 days |
Opioids | ||||||||
| Drug class & drug analytes | Common drug names | Street names | Schedule | Ways used | Addiction | Drug metabolite | Detection time: urine | Detection time: oral fluid |
| Buprenorphine | Suboxone®, Subutex®, Buprenex®, Butrans® | N/A | Schedule III | Sublingual; intramuscular; intravenous; transdermal; intranasal; rectal | Risk of physical and psychological dependence with prolonged use. Withdrawal symptoms are typically less severe than other opioids. | Buprenorphine, Norbuprenorphine | 3-5+ days | 1-2+ days |
| Fentanyl | Actiq®, Fentora®, Onsolis®, Duragesic®, Sublimaze® | N/A | Schedule II | Transdermal; intramuscular; intravenous; oral; sublingual; buccal | Moderate-to-high risk of physical or psychological dependence. Risk of postacute-withdrawal syndrome leading to possible psychiatric disorders, depression, anxiety, etc. | Fentanyl, Norfentanyl | 1-4 days | 1-3 days |
| Meperidine | Demerol® | Demmies, Painkiller | Schedule II | Oral; intranasal; rectal; intravenous | Due to rapid onset, meperidine is more likely to be abused than other prescription opioids. Like other opioids, there is a potential for physical dependence. | Meperidine, Normeperidine | 1-3 days | 1-2 days |
| Methadone | Methodose®, Dolophine® | Dollies, Meth | Schedule II | Oral; intravenous; insufflation; sublingual; rectal | According to some physicians, methadone causes less of a euphoric high. Often used as an intermediate drug in opioid addiction recovery programs. | Methadone, EDDP (2-ethylidene-1,5-dimethyl-3,3-diphenyl pyrrolidine | 1-7 days | 1-2 days |
| Pentazocine | Talwin® | T’s | Schedule III | Oral; intravenous; intramuscular | Moderate-to-low physical dependence risk. May have risk of psychological dependence. | Pentazocine | 1-3 days | 1-2 days |
| Propoxyphene | Darvocet®, Darvon® | Painkiller | Schedule IV | Oral; intravenous; rectal | Risk of limited physical or psychological dependence with prolonged use. | Norpropoxyphene, Propoxyphene | 1-7 days | 1-2 days |
| Tapentadol | Nucynta® | N/A | Schedule II | Oral | High risk of physical or psychological dependence. Withdrawal symptoms may include anxiety, sweating, trouble sleeping, etc. | Tapentadol, Desmethyltapentadol | 1-3 days | 1-2 days |
| Tramadol | Ryzolt®, Ultracet®, Ultram® | N/A | Schedule IV | Oral; intravenous; intramuscular; rectal; sublingual; buccal; intranasal | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, depression, anguish, sweating, restless legs, etc. | Tramadol, O-desmethyltramadol | 1-3 days | 1-2 days |
Stimulants | ||||||||
| Drug class & drug analytes | Common drug names | Street names | Schedule | Ways used | Addiction | Drug metabolite | Detection time: urine | Detection time: oral fluid |
| Amphetamine | Adderall®, Benzedrine®, Dexedrine® | Aimies, Back dex, Bennies, Black beauties, Brain pills, Bumblebees, Dartwheels, Dexies, Marathons, Pep pills, Pixies, Road dope, Speed, Truck drivers, Uppers | Schedule II | Oral, typical dosage: 5-15 mg | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include extreme hunger, fatigue, shaking, seizures, arrhythmia, etc. | Amphetamine | 2-4+ days | 1-3 days |
| Methylphenidate | Ritalin®, Concerta®, Methylin®, Provigil® | N/A | Schedule II | Oral; transdermal | High risk of physical or psychological dependence. Withdrawal symptoms may include depression, extreme fatigue, etc. | Methylphenidate, Ritalinic acid | 2-4 days | 1-2 days |
| Nicotine | Nicorette®, Nicoderm® | N/A | Nonscheduled | Smoking; insufflation; oral; transdermal; intrabuccal; vaporized; buccal | High potential for physical or psychological dependence. Withdrawal symptoms may include anxiety, irritability, headache, hunger, craving for cigarettes, etc. | Cotinine, 3-OH-cotinine | 2-4 days | 2-4 days |
Common drugs of abuse: Benzodiazepines | ||||||||
| Drug class & drug analytes | Common drug names | Street names | Schedule | Ways used | Addiction | Drug metabolite | Detection time: urine | Detection time: oral fluid |
| Alprazolam | Xanax®, Niravam®, Xanor® | Downs, Nerve pills, Tranks | Schedule IV | Oral | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc. | Alprazolam, α-hydroxy alprazolam | 2-8 days | 1-2 days |
| Chlordiazepoxide | Angirex®, Elenium®, Klopoxid®, Librax®, Libritabs®, Librium®, Mesural®, Mul-tum®, Novapam®, Risolid®, Silibrin®, Sonimen®, Tropium® | Downs, Nerve pills, Tranks | Schedule IV | Oral; intramuscular | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc. | Nordiazepam, Oxazepam | 1-7 days | 1-2 days |
| Clonazepam | Klonopin® | Downs, Nerve pills, Tranks | Schedule IV | Oral; intravenous; intramuscular; sublingual | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc. | Clonazepam, 7-amino clonazepam | 3-14 days | 1-2 days |
| Clorazepate | Tranxene®, Novo-Clopate® | Downs, Nerve pills, Tranks | Schedule IV | Oral | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc. | Nordiazepam, Oxazepam | 1-7 days | 1-2 days |
| Diazepam | Valium® | Downs, Nerve pills, Tranks | Schedule IV | Oral; intramuscular; intravenous; suppository | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc. | Diazepam, Temazepam, Nordiazepam, Oxazepam | 3-14 days | 1-2 days |
| Flurazepam | Dalmane®, Dalmadorm® | Downs, Nerve pills, Tranks | Schedule IV | Oral | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc. | N1-desalkyl-flurazepam, hydroxyethyl-flurazepam | 1-3 days | 1-2 days |
| Lorazepam | Ativan® Lorax®, Emotavil® | Downs, Nerve pills, Tranks | Schedule IV | Oral; intramuscular; intravenous; sublingual; transdermal | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc. | Lorazepam | 2-5 days | 1-2 days |
| Midazolam | Versed, Dormicum, Hypnovel® | Downs, Nerve pills, Tranks | Schedule IV | Oral; intramuscular; intravenous; parenteral | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc. | α-Hydroxymidazolam | 1-3 days | 1-2 days |
| Oxazepam | Murelax®, Serax®, Serepax®, Alepam®, Adumbran® | Downs, Nerve pills, Tranks | Schedule IV | Oral | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc. | Oxazepam | 1-3 days 4-6 weeks Chronic use* | 1-2 days |
| Temazepam | Restoril®, Tenox®, Euhypnos® | King Kong pills, jellies, jelly, Edinburgh eccies, tams, terms, mazzies, temazies, tammies, temmies, beans, eggs, green eggs, wobbly eggs, knockouts, hardball, norries, oranges, rugby balls, ruggers, terminators, red and blue, no-gos, blackout, green devils, drunk pills, brainwash, mind erasers, tem-tems, mommy’s big helper, vitamin T, bit T, TZ | Schedule IV | Oral | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc. | Temazepam, Oxazepam | 1-4 days | 1-2 days |
Muscle Relaxants | ||||||||
| Drug class & drug analytes | Common drug names | Street names | Schedule | Ways used | Addiction | Drug metabolite | Detection time: urine | Detection time: oral fluid |
| Carisoprodol | Soma®, Soprodal® | Dance, DS, Las Vegas cocktail, Soma coma, Wallace 200s | Schedule IV | Oral | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include stomach pain, sleep problems, headache, nausea, seizure, etc. | Carisoprodol, Meprobamate | 2-5 days | 1-2 days |
| Meprobamate | Miltown®, Equanil®, Meprospan® | Dance, DS, Las Vegas cocktail, Soma coma, Wallace 200s | Schedule IV | Oral | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include stomach pain, sleep problems, headache, nausea, seizure, etc. | Meprobamate | 2-5 days | 2-3 days |
Barbiturates | ||||||||
| Amobarbital | Amytal® | Yellow jackets, Angels, Downers, Red birds, Phennies, Yellows, Tootsies | Schedule III | Oral; intravenous; intramuscular; rectal | Risk of physical and psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, restlessness, insomnia, dizziness, seizures, psychosis, etc. | Amobarbital | 3-10 days | 1-2 days |
| Butabarbital | Butisol®, Butibel® | Yellow jackets, Angels, Downers, Red birds, Phennies, Yellows, Tootsies | Schedule III | Oral | Risk of physical and psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, restlessness, insomnia, dizziness, seizures, psychosis, etc. | Butabarbital | 1 day–3 weeks | 1-2 days |
| Butalbital | Fiorinal®, Fioricet® | Yellow jackets, Angels, Downers, Red birds, Phennies, Yellows, Tootsies | Schedule III | Oral | Risk of physical and psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, restlessness, insomnia, dizziness, seizures, psychosis, etc. | Butalbital | 3-10 days | 1-2 days |
| Pentobarbital | Nembutal® | Yellow jackets, Angels, Downers, Red birds, Phennies, Yellows, Tootsies | Schedule III | Oral; intravenous; intramuscular; rectal | Risk of physical and psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, restlessness, insomnia, dizziness, seizures, psychosis, etc. | Pentobarbital | 3-10 days | 1-2 days |
| Phenobarbital | Belladonna®, Luminal® | Yellow jackets, Angels, Downers, Red birds, Phennies, Yellows, Tootsies | Schedule III | Oral; intravenous; intramuscular; rectal | Risk of physical and psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, restlessness, insomnia, dizziness, seizures, psychosis, etc. | Phenobarbital | 1 day–4 weeks | 1-2 days |
| Secobarbital | Seconal® | Yellow jackets, Angels, Downers, Red birds, Phennies, Yellows, Tootsies, Barbs, reds | Schedule III | Oral | Risk of physical and psychological dependence with prolonged use. Withdrawal symptoms may include anxiety, restlessness, insomnia, dizziness, seizures, psychosis, etc. | Secobarbital | 3-10 days | 1-2 days |
Tricyclic Antidepressants (TCA) | ||||||||
| Drug class & drug analytes | Common drug names | Street names | Schedule | Ways used | Addiction | Drug metabolite | Detection time: urine | Detection time: oral fluid |
| Amitriptyline | Elavil®, Endep® | N/A | Nonscheduled | Oral | Little to no risk of physical or psychological dependence; however, there are withdrawal symptoms such as agitation, anxiety, insomnia, and, sometimes, a rebound of mania or depression. | Amitriptyline, Nortriptyline | 2-14 days | 1-2 days |
| Desipramine | Norpramin® | N/A | Nonscheduled | Oral | Little to no risk of physical or psychological dependence; however, there are withdrawal symptoms such as agitation, anxiety, insomnia, and, sometimes, a rebound of mania or depression. | Desipramine | 3-15 days | 1-2 days |
| Doxepin | Sinaquan®, Adapin® | N/A | Nonscheduled | Oral; intramuscular; intravenous | Little to no risk of physical or psychological dependence; however, there are withdrawal symptoms such as agitation, anxiety, insomnia, and, sometimes, a rebound of mania or depression. | Doxepin, Desmethyldoxepin | 2-8 days | 1-2 days |
| Imipramine | Tofranil®, Tofranil-PM (desipramine metabolite) | N/A | Nonscheduled | Oral | Little to no risk of physical or psychological dependence; however, there are withdrawal symptoms such as agitation, anxiety, insomnia, and, sometimes, a rebound of mania or depression. | Imipramine, Desipramine | 1-6 days | 1-2 days |
| Maprotiline | Ludiomil®, Deprilept®, Psymion® | N/A | Nonscheduled | Oral; intramuscular; intravenous | Little to no risk of physical or psychological dependence; however, there are withdrawal symptoms such as agitation, anxiety, insomnia, and, sometimes, a rebound of mania or depression. | Maprotiline | 7-10 days | 1-2 days |
| Nortriptyline | Pamelor®, Aventyl® (amitriptyline metabolite) | N/A | Nonscheduled | Oral | Little to no risk of physical or psychological dependence; however, there are withdrawal symptoms such as agitation, anxiety, insomnia, and, sometimes, a rebound of mania or depression. | Nortriptyline, Hydroxynortriptyline | 4-21+ days | 1-2 days |
Neuropathic | ||||||||
| Drug class & drug analytes | Common drug names | Street names | Schedule | Ways used | Addiction | Drug metabolite | Detection time: urine | Detection time: oral fluid |
| Gabapentin | Neurontin® | N/A | Schedule V | Oral | Abuse may lead to limited physical dependence or psychological dependence. Withdrawal symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc. | Gabapentin | 1-3 days | 1-2 days |
| Pregabalin | Lyrica® | Lycia | Schedule V | Oral; intravenous; insufflation | Abuse may lead to limited physical dependence or psychological dependence. Withdrawal symptoms may include anxiety, irritability, insomnia, sensory disturbances, etc. | Pregabalin | 1-3 days | 1-2 days |
Selective Serotonin Reuptake Inhibitors (SSRI) | ||||||||
| Fluoxetine | Prozac®, Sarafem®, Fontex® | N/A | Nonscheduled | Oral | Low risk of physical or psychological dependence. Withdrawal symptoms may include flu, headache, chills, fatigue, nausea, hallucinations, suicidal thoughts, etc. | Fluoxetine, norfluoxetine | No data | No data |
| Sertraline | Zoloft®, Lustral® | N/A | Nonscheduled | Oral | Low risk of physical or psychological dependence. Withdrawal symptoms may include flu, headache, chills, fatigue, nausea, hallucinations, suicidal thoughts, etc. | Sertraline, Norsertraline | No data | No data |
Sedatives / Hypnotics | ||||||||
| Methaqualone | Quaalude | Ludes | Schedule IV | Oral | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include restlessness, irritability, antisocial behavior, insomnia, headache, etc. | Methaqualone | 2-4 days | No data |
| Zaleplon | Sonata®, Starnoc® | N/A | Schedule IV | Oral; intranasal | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include restlessness, irritability, antisocial behavior, insomnia, headache, etc. | Zaleplon | No data | |
| Zolpidem | Ambien®, Stilnox®, Sublinox® | A-minus, Zombie pills, No-go pills | Schedule IV | Oral; sublingual; oromucosal | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include restlessness, irritability, antisocial behavior, insomnia, headache, etc. | Zolpidem, Carboxyzolpidem | 1-2 days | 1-2 days |
| Zopiclone | Imovane® | Zimmers, Zimmies, Zim-zims, Zoppies | Schedule IV | Oral | Risk of limited physical or psychological dependence with prolonged use. Withdrawal symptoms may include restlessness, irritability, antisocial behavior, insomnia, headache, etc. | Zopiclone | 1-2.5 days | No data |
Common drugs of abuse: Illicit and Non-Prescription | ||||||||
| Drug class & drug analytes | Common drug names | Street names | Schedule | Ways used | Addiction | Drug metabolite | Detection time: urine | Detection time: oral fluid |
| Alcohol | N/A | Booze | Nonscheduled | Oral; intramuscular; intravenous; topical | Low-to-high risk of physical or psychological dependence. Symptoms include tolerance, withdrawal, perpetually increasing consumption, persistent desire, lost time drinking or recovering, abandonment of social activities for alcohol, and continued use despite knowledge of physical or psychological damage. | Alcohol, Ethyl glucuronide (EtG), Ethyl sulfate (EtS) | Alcohol: 1-2 days Blood alcohol decreases .02 mg% per hour EtG/EtS: up to 80 hours | 6-24 hours |
| Cathinones | Bath salts, or veiled as ecstasy | N/A | MDPV and mephedrone Schedule I, all others are drugs of concern. | Oral; intranasal; insufflation; intravenous | High potential for abuse and physical or psychological dependence. Withdrawal symptoms may include a runny nose, nosebleeds, cravings for sweets, muscle spasm, etc. | MDPV, Pyrovalerone, 3-fluoro-methcathinone, Butylone, Ethylone, MDAI, Methylone, Naphyrone, Buphedrone, Mephedrone, Methe-drone, Eutylone, PVP | 2-3 days | 1-2 days |
| Cocaine | N/A | Aunt nora, barbs, blow, coke, dream, foo-foo dust, her, king’s habit, Peruvian lady, snow, stardust, witch, zip | Schedule II | Topical; oral; insufflation; intravenous | High risk of physical or psychological dependence. Withdrawal symptoms may include unpleasant dreams, insomnia, or hypersomnia. | Benzoylecgonine | 1-7 days | 1-2 days |
| Dextromethorphan | N/A | Dex, DXM, robo, skittles, syrup, triple-c, vitamin D, tussin | Nonscheduled | Oral | Low potential for physical or psychological dependence. Withdrawal symptoms may include insomnia, anxiety, restlessness, vomiting, severe weight loss, diarrhea, etc. | Dextromethorphan | 24 hours | N/A |
| Heroin | N/A | Dragon, dope, hera, H, big H, white, China white, white nurse, white lady, white horse, boy, black tar, black pearl, black stuff, black eagle, brown crystal, brown sugar, brown tape, brown rhine, Mexican brown, Mexican mud, Mexican horse, junk, tar, snowball, snow, white boy, smack, scag, scat, sack, skunk, number 3, 4, 8 | Schedule I | Inhalation; transmucosal; intravenous; oral; intranasal; rectal; intramuscular | High potential for physical or psychological dependence. Withdrawal symptoms include sweating, malaise, anxiety, depression, insomnia, cold sweats, etc. | 6-MAM, Morphine, Codeine | 6-MAM- 6-8 hours 1-3 days | 8 hours |
| Ketamine | Ketanest®, Ketaset®, Ketalar® | K, ket, special K, vitamin K, vit K, kit kat, keller, kelly’s day, green, blind squid, cat valium, purple, special la coke, super acid, super C | Schedule III | Oral; intravenous; intramuscular; insufflation; topical | Moderate risk of physical or psychological dependence. Withdrawal symptoms may include chills, intense cravings, restlessness, nightmares, anxiety, tremors, sweating, etc. | Ketamine, Norketamine | 2-4 days | No data |
| Kratom | Mitragyna speciosa | Krathom, Biak-biak, Cratom, Mitragyne, Gratom | Drug of concern | Smoking; chewing | Abuse risk debated. Frequent use is known to cause nervousness, skin darkening, constipation, nausea, etc. Can sometimes cause cross-tolerance for morphine. | 7-hydroxymitragynine | No data | No data |
| Lysergic acid diethylamide | N/A | LSD, acid | Schedule I | Oral; intravenous; ocular; intramuscular | High potential of abuse despite low addiction potential. Discontinuation symptoms may include hallucinations, depression, anxiety, schizophrenia, confusion, etc. | N-Desmethyl-LSD, hydroxy- LSD, 2-oxo-LSD, 2-oxo-3-hydroxy-LSD | 1.5-5 days | 1-2 days |
| Marijuana (THC) | Marinol®, Marijuana, Pot, Reefer | Weed, pot, reefer, grass, dope, ganja, mary jane, hash, herb, aunt mary, skunk, boom, chronic, cheeba, blunt, ashes, baby bhang, bammy, blanket, bomber, boom, broccoli, cripple, dagga, dinkie dow, ding, dona juana, flower, flower tops, gasper, giggle smoke, good giggles, good butt, hot stick, jay, jolly green, joy smoke, joy stick, roach | Schedule I | Smoking; oral | High risk of physical or psychological dependence. Withdrawal symptoms may include irritability, sleeplessness, decreased appetite, anxiety, drug craving, etc. | 11-OH-THC, 11-nor-9-carboxy-THC (plus more than 100 possible others) | Single use: 3 days; moderate use: 5-7 days; daily use: 10-15 days; long term: >30 days | 24+ hours |
| Methylenedioxy-methamphet-amine (MDMA) | Ecstasy | X, E, XTC, adam, beans, candy, dancing shoes, disco biscuits, doves, e-bombs, egg rolls, happy pill, hug drug, love drug, macolm, scooby snacks, smartees, sweets, skittles, thizz, vitamin E, vitamin X, vowels | Schedule I | Oral, typical dosage: 50-150 mg | High potential for abuse despite low physical addiction potential. Addiction potential is debatable. Withdrawal symptoms may include fatigue, loss of appetite, depression, etc. | MDMA, MDA | 1-3 days | 1-2 days |
| Methamphetamine | Methadrine, Desoxyn®, Desfedrin®, Ampedroxyn® | &Crystal meth, crystal, meth, christina, tina, cris, cristy, ice, crank, speed, geep, geeter, getgo, go fast, poor man’s coke, redneck cocaine, working man’s cocaine, trash, garbage, wash | Schedule II | Oral, typical dosage: 5-15 mg, intravenous, typical dosage: 20-40 mg | High potential for abuse and physical or psychological dependence. Withdrawal symptoms may include irritability, depression, fearfulness, loss of energy, nausea, tremors, sweating, palpitations, increased appetite, etc. | Methamphetamine, Amphetamine | 1-4+ days | 1-3 days |
| Methylenedioxy-amphetamine (MDA) | N/A | MDA, Love drug | Schedule I | Oral; sublingual | High potential for abuse despite low physical addiction potential. | MDA | 1-3 days | 1-2 days |
| Phencyclidine | PCP | Hog, Angel dust, Loveboat, Lovely | Schedule II | Smoking; insufflation; oral | High risk of abuse and physical dependence. Withdrawal symptoms may include depression, anxiety, hypersomnia, poor memory, confusion, violent behavior, hallucinations, delusions, etc. | PCP | 2-30 days | 1-2 days |
| Piperazines | “Bath salts,” or veiled as ecstasy | N/A | BZP Schedule I, all others are drugs of concern. | Oral; intranasal; insufflation; intravenous | High potential for abuse and physical or psychological dependence. Withdrawal symptoms may include runny nose, nosebleeds, cravings for sweets, muscle spasm, etc. | meta-Chlorophenylpiperazine (mCPP), 3-trifluoromethylphenylpi-perazine (TFMPP), Benzylpiperazine (BZP) | 2-3 days | 1-2 days |
| Synthetic cannabinoids | K2, Spice | K2, Spice, Synthetic marijuana, Fake pot | Schedule I | Smoking, infusion | High risk of abuse. Withdrawal symptoms may include internal unrest, tremor, palpitations, headache, nausea, vomiting, depression, etc. | AKB-48, AM-1248, AM-2201, AM-694, JWH-018, JWH-019, JWH-073, JWH-081, JWH-122, JWH-200, JWH-203, JWH-210, JWH-250, JWH-398, MAM-2201, RCS-4, RCS-8, UR-144, XLR-11 | 1-3 days (single dose only) | 12-48 hours |